Lentiviral vector design
Design cassettes for overexpression, shRNA, and CRISPR with the right promoter and elements for your target cell type.
Lentivirus Applications Resource
Lentiviral vectors are a cornerstone of gene delivery in molecular and cell biology. Integrative vectors stably insert genetic elements into the target cell genome, enabling long-term expression that is especially valuable when sustained genetic modification or prolonged phenotypic observation is required. In research, lentivirus supports gene overexpression, shRNA-mediated knockdown, CRISPR gene editing, CRISPRi/CRISPRa regulation, stable cell-line construction, reporter labeling, stem-cell studies, and functional-genomics screening—a breadth that makes it a single platform for many experimental questions.
Direct Answer
A common misunderstanding is to treat lentivirus as if it performs gene editing itself. In fact, lentivirus delivers the genetic elements—the GOI, shRNA, Cas, or sgRNA—into the target cell; the actual knockdown or editing is carried out by the RNAi or CRISPR machinery that those elements encode.
Similarly, knockdown and knockout are different concepts. shRNA reduces expression through RNA interference, whereas knockout requires genome editing such as CRISPR/Cas. Keeping these distinctions clear is essential to designing the right experiment.
The key principle: choose the vector and payload to match the intended biological outcome—expression, knockdown, regulation, or editing—rather than treating lentivirus as a one-size-fits-all tool.
Deliver a gene of interest for sustained expression to study function, signaling, and drug targets across many cell types.
shRNA delivered by lentivirus lowers target expression long-term, ideal for gene-function and pathway studies that outlast transient siRNA.
Lentivirus carries Cas, sgRNA, or other CRISPR components to establish gene knockout or site-specific editing systems in target cells.
Deliver dCas-based systems to repress or activate gene expression, enabling reversible gene-regulation and large-scale screening.
Lentivirus builds stable cell models and reporters, and delivers shRNA/sgRNA/ORF libraries for high-throughput functional-genomics screening.
Application Map
From single-gene studies to genome-wide screens, lentivirus spans a wide range of research modes. Each maps to a distinct payload and experimental goal.
| Application | Primary use |
|---|---|
| Gene overexpression | Stable expression of a gene of interest |
| Gene knockdown | shRNA-based reduction of target gene expression |
| CRISPR gene editing | Delivery of Cas and sgRNA editing components |
| CRISPRi / CRISPRa | Transcriptional repression or activation of target genes |
| Stable cell lines | Long-term genetically modified cell models |
| Reporter genes | GFP, mCherry, and other fluorescent labeling |
| Stem-cell research | Differentiation and cell-fate regulation studies |
| High-throughput screening | shRNA/sgRNA library and functional-genomics screening |
For gene-silencing and library-based workflows, Creative Biolabs provides dedicated custom shRNA lentivirus and shRNA library services.
Choosing a Mode
Match the payload and design to the biological question, then validate the result with appropriate controls.
Decide between expression, knockdown, regulation, or editing before choosing a payload.
Use a GOI for overexpression, shRNA for knockdown, or Cas/sgRNA for editing and regulation.
Match promoter, cassette, and silencing or editing elements to your cell type.
Confirm expression or editing, and perform single-cell cloning if a clonal line is required.
Result Determinants
Lentiviral outcome depends on more than the payload. These variables determine whether the intended expression, knockdown, or editing is actually achieved.
Promoter choice sets expression strength and cell-type compatibility, directly affecting the observed phenotype.
Codon usage and sequence features influence expression level and stability in the target cell.
Transduction and expression vary across cell types, so the model must be matched to the experiment.
MOI and delivery efficiency determine the fraction of cells that receive and express the payload.
Correct cassette architecture and lentiviral vector design prevent low titer or poor expression.
Selection markers and single-cell cloning convert a mixed pool into a defined, homogeneous cell line.
Decision Framework
These rules route each research objective to the most appropriate lentiviral approach, avoiding common mismatches between payload and goal.
Choose: overexpression of the GOI with matched controls.
Use case: proliferation, apoptosis, migration, and pathway studies.
Choose: shRNA knockdown when sustained suppression is needed.
Use case: gene-function and pathway studies that outlast transient siRNA.
Choose: CRISPR/Cas delivery of Cas and sgRNA for actual knockout or editing.
Use case: gene knockout, site-specific editing, and CRISPR screening.
Choose: CRISPRi or CRISPRa via dCas-based systems.
Use case: gene-regulation studies and large-scale screens.
Choose: stable reporter, overexpression, or shRNA/sgRNA library delivery.
Use case: stable cell lines, cell labeling, and functional-genomics screening.
Application Outputs
Each lentiviral mode delivers a defined experimental outcome.
Sustained GOI output.
Reduced target expression.
Knockout or site-specific change.
Defined cell line or screen hit.
From Question to Evidence
Creative Biolabs can support your lentiviral research from design through production, titration, and analysis, covering the full range of overexpression, knockdown, and CRISPR applications.
Design cassettes for overexpression, shRNA, and CRISPR with the right promoter and elements for your target cell type.
Produce high-titer lentivirus for reliable transduction in stable cell-line construction and screening workflows.
Leverage custom shRNA lentivirus and libraries for gene silencing and functional-genomics screening.
Deliver Cas and sgRNA components and build editing or CRISPRi/CRISPRa systems for knockout and gene regulation.
Confirm infectious titer so transduction and MOI calculations are accurate and reproducible.
Selected Reading
Naldini L, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272(5259):263–267. https://doi.org/10.1126/science.272.5259.263.
Moffat J, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124(6):1283–1298. https://doi.org/10.1016/j.cell.2006.01.040.
Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nature Methods. 2014;11(8):783–784. https://doi.org/10.1038/nmeth.3047.
FAQ
Tell us about your project, and our experts will get back to you with a customized quote and proposal.